Welcome to LookChem.com Sign In|Join Free
  • or
[1,2,4]thiadiazol-5-yl-carbamic acid phenyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1449669-14-0

Post Buying Request

1449669-14-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1449669-14-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1449669-14-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,4,9,6,6 and 9 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1449669-14:
(9*1)+(8*4)+(7*4)+(6*9)+(5*6)+(4*6)+(3*9)+(2*1)+(1*4)=210
210 % 10 = 0
So 1449669-14-0 is a valid CAS Registry Number.

1449669-14-0Relevant academic research and scientific papers

SUBSTITUTED 1,2,4-THIADIAZOLYLPYRROLONES AND 1,2,4-THIADIAZOLYLHYDANTOINS AND SALTS THEREOF AND USE THEREOF AS HERBICIDES

-

Paragraph 0216-0217, (2020/04/10)

The invention relates to substituted 1,2,4-thiadiazolyl pyrrolones and 1,2,4-thiadiazolyl hydantoins of general formula (I) and salts thereof, wherein the groups of general formula (I) are defined as cited in the description, and to the use thereof as herbicides, in particular for controlling weeds and/or weed grasses in crops of useful plants and/or as plant growth regulators for influencing the growth of crops of useful plants.

IMIDAZO [4, 5 -C] PYRIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

-

Paragraph 00499, (2013/08/28)

Wherein R1, L1, R3, R4, Cy, L2 and R5 are as defined herein. Novel imidazolopyridines according to Formula I, able to inhibit JAK are disclosed, these compounds may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, allergic or inflammatory conditions, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1449669-14-0